For best results when printing this announcement, please click on the link
below:
http://pdf.reuters.com/Regnews/regnews.asp?i=43059c3bf0e37541&u=urn:newsml:reuters.com:20140715:nRSO2827Ma
RNS Number : 2827M
Futura Medical PLC
15 July 2014
For immediate release 15 July 2014
Futura Medical plc
("Futura" or the "Company")
Notice of Interim Results
Futura Medical plc (AIM: FUM), the innovative healthcare company focused on
advanced transdermal technology, will announce its interim results for the six
months ended 30 June 2014 on Thursday 11 September 2014.
A briefing for analysts will be held at 10.00am on the morning of the results
at the offices of Buchanan, 107 Cheapside, London EC2V 6DN.
There will be a webcast of the analyst presentation. If you would like to
listen to the webcast, please log on to the following web address
approximately 5 minutes before 10.00am on the day of results:
http://media.buchanan.uk.com/2014/futuramedical110914/registration.asp
A recording of the webcast will also be made available at
www.futuramedical.com and www.buchanan.uk.com, following the results meeting.
For more information, or to register attendance, please contact Buchanan on
020 7466 5000.
For any further information please contact:
Futura Medical plc
James Barder, Chief Executive Tel: +44 (0)1483 685 670
mail to: james.barder@futuramedical.com www.futuramedical.com
N+1 Singer (Nominated Adviser and Broker)
Aubrey Powell - Corporate FinanceBrough Ransom - Sales Tel:+44 (0) 20 7496 3000
For media enquiries please contact:
Buchanan
Mark Court / Fiona Henson / Sophie Cowles Tel: +44 (0)20 7466 5000
Notes to Editors
Futura Medical plc
Futura Medical is a pharmaceutical group that develops innovative products for
consumer healthcare. The Company is developing a portfolio of products and its
strategy is to license their manufacture and distribution to major
pharmaceutical and healthcare groups.
Futura is based in Guildford, Surrey, and its shares trade on the AIM market
of the London Stock Exchange.
www.futuramedical.com
This information is provided by RNS
The company news service from the London Stock Exchange